 <h1>Sulfamylon Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>mafenide topical</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about mafenide topical. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Sulfamylon.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to mafenide topical: topical cream, topical powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, mafenide topical (the active ingredient contained in Sulfamylon) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking mafenide topical:</p><p>
<i>Less common</i>
</p><ul>
<li>Itching</li>
<li>skin rash or redness</li>
<li>swelling of face or skin</li>
<li>wheezing or troubled breathing</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bleeding or oozing of skin</li>
<li>drowsiness</li>
<li>fast, deep breathing</li>
<li>nausea</li>
</ul><p>
<i>Incidence unknown</i>
</p><ul>
<li>Black, tarry stools</li>
<li>chest pain</li>
<li>chills</li>
<li>cough or hoarseness</li>
<li>dark urine</li>
<li>dizziness</li>
<li>fever</li>
<li>fluid-filled skin blisters</li>
<li>light-colored stools</li>
<li>lower back or side pain</li>
<li>numbness to feet, hands and around mouth</li>
<li>painful or difficult urination</li>
<li>rapid shallow breathing </li>
<li>sensitivity to the sun</li>
<li>shortness of breath</li>
<li>skin thinness</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on lips or in mouth</li>
<li>swollen glands</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of mafenide topical may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Pain or burning feeling on treated area(s)</li>
</ul><p>
<i>Incidence unknown</i>
</p><ul>
<li>Blisters</li>
<li>flushing</li>
<li>raised red swellings on the skin, lips, tongue, or in the throat</li>
<li>redness of skin</li>
<li>skin rash</li>
<li>softening of the skin</li>
<li>swelling</li>
<li>unusually warm skin</li>
</ul><p>
<!-- end topical cream, topical powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to mafenide topical: compounding powder, topical cream, topical powder for reconstitution</i></p><h3>General</h3><p>In the clinical setting of severe burns, it is difficult to distinguish between an adverse reaction to this drug and burn sequelae.  In a clinical study in pediatric patients with acute burns requiring autografts who received the topical solution in addition to double antibiotic solution (DAB) wound therapy (neomycin sulfate 40 mg and polymyxin B 200,000 units/L), the incidence of rash (4.6%) and itching (2.8%) in the group who received this drug was not different from that experienced with DAB dressings alone (5.7% and 1.3%, respectively).<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Pain, burning sensation, rash, pruritus, excoriation, bleeding<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Erythema, skin maceration, hives, blisters<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Tachypnea, hyperventilation, partial pressure of carbon dioxide decreased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Metabolic acidosis, serum chloride increased<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Eosinophilia, bone marrow depression, fatal hemolytic anemia, disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Face edema, swelling, porphyria<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Sulfamylon cream (mafenide topical)." Dow Hickam Pharmaceuticals Inc, Sugar Land, TX. </p><p id="ref_2">2. "Product Information. Sulfamylon (mafenide topical)." Bertek Pharmaceuticals Inc, Sugar Land, TX. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Sulfamylon (mafenide topical)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: topical antibiotics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sulfamylon Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Burns, External</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to mafenide topical: compounding powder, topical cream, topical powder for reconstitution</i></p><h3>General</h3><p>In the clinical setting of severe burns, it is difficult to distinguish between an adverse reaction to this drug and burn sequelae.  In a clinical study in pediatric patients with acute burns requiring autografts who received the topical solution in addition to double antibiotic solution (DAB) wound therapy (neomycin sulfate 40 mg and polymyxin B 200,000 units/L), the incidence of rash (4.6%) and itching (2.8%) in the group who received this drug was not different from that experienced with DAB dressings alone (5.7% and 1.3%, respectively).<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Pain, burning sensation, rash, pruritus, excoriation, bleeding<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Erythema, skin maceration, hives, blisters<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Frequency not reported</b>: Tachypnea, hyperventilation, partial pressure of carbon dioxide decreased<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Metabolic acidosis, serum chloride increased<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Eosinophilia, bone marrow depression, fatal hemolytic anemia, disseminated intravascular coagulation<sup>[Ref]</sup></p><h3>Other</h3><p><b>Frequency not reported</b>: Face edema, swelling, porphyria<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Sulfamylon cream (mafenide topical)." Dow Hickam Pharmaceuticals Inc, Sugar Land, TX. </p><p id="ref_2">2. "Product Information. Sulfamylon (mafenide topical)." Bertek Pharmaceuticals Inc, Sugar Land, TX. </p><h2>More about Sulfamylon (mafenide topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: topical antibiotics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Sulfamylon Topical &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Burns, External</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>